Alibaba Health Information Technology Ltd ALBHF

Morningstar Rating
$0.36 0.00 (1.27%)
View Full Chart

About Quantitative Ratings

Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.

Price vs Fair Value

ALBHF is trading within a range we consider fairly valued.
Price
$0.36
Fair Value
LOCK|&<HKVT
Uncertainty
LOCK|ch
1-Star Price
LOCK|Q?<>^
5-Star Price
LOCK|TksZS!
Economic Moat
LOCK|srg$
Capital Allocation
—

News

Trading Information

Previous Close Price
$0.35
Day Range
$0.36–0.36
52-Week Range
$0.34–0.88
Bid/Ask
$0.30 / $1.14
Shares Outstanding
16.18B
Market Cap
$5.78B
Volume/Avg
155 / 2,148

Key Statistics

Price/Earnings (Normalized)
20.22
Price/Sales
1.19
Dividend Yield (Trailing)
2.44%
Dividend Yield (Forward)
2.44%
Dividend Payment Schedule
Sep
Total Yield
2.44%

Company Profile

Alibaba Health is one of China's leading e-commerce platforms specializing in healthcare-related products, including prescription drugs, over-the-counter drugs, traditional Chinese medicine, health foods, and so on. The company operates both a third-party B2C service, or 3P, and its own direct-to-consumer business, or 1P, with its own inventory, which can both be accessed by Alibaba’s Tmall app and Alipay. The company also provides online consultation services in a separate app, although its e-commerce businesses remain its core competency in the long term. E-commerce accounted for 93% of revenue in fiscal year 2022. We estimate that AliHealth holds about 45% of market share in the industry in terms of gross merchandise value. AliHealth is 63.74% owned by its parent company, Alibaba Group.
Sector
Healthcare
Industry
Pharmaceutical Retailers
Stock Style Box
Mid Core
Total Number of Employees
1,429

Competitors

Valuation

Metric
ALBHF
01833
06618
Price/Earnings (Normalized)
20.2229.5815.53
Price/Book Value
2.301.161.62
Price/Sales
1.192.221.31
Price/Cash Flow
19.1429.3712.33
Price/Earnings
ALBHF
01833
06618

Financial Strength

Metric
ALBHF
01833
06618
Quick Ratio
2.482.582.32
Current Ratio
3.033.062.69
Interest Coverage
1,292.58—387.13
Quick Ratio
ALBHF
01833
06618

Profitability

Metric
ALBHF
01833
06618
Return on Assets (Normalized)
10.33%3.64%8.40%
Return on Equity (Normalized)
13.99%4.97%11.42%
Return on Invested Capital (Normalized)
11.11%3.94%9.43%
Return on Assets
ALBHF
01833
06618

Pharmaceutical Retailers Industry Comparables

1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
JD Health International Inc
JDHIF
—LOCK|SQ?!$14B
JD Health International Inc ADR
JDHIY
—LOCK|&X%T$14B
Raia Drogasil SA ADR
RADLY
—LOCK|wqdW$6B
MatsukiyoCocokara & Co
MSMKF
—LOCK|?>^$6B
Alibaba Health Information Technology Ltd ADR
ALBBY
—LOCK|<#^q$6B
COSMOS Pharmaceutical Corp
CSMYF
—LOCK|f?$3B
Clicks Group Ltd ADR
CLCGY
—LOCK|@%s$<$3B
Clicks Group Ltd
CCKRF
—LOCK|@@@F&$3B
Sugi Holdings Co Ltd
SGIPF
—LOCK|$?$3B

Sponsor Center